Anvia Therapeutics
Biotechnology Research • 
Manhattan, New York, United States • 1-10 Employees
Company overview
| Headquarters | Manhattan, New York, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
Key Contacts at Anvia Therapeutics
Anna L. Barry
Co-Founder, President & Ceo
Claire Tseng
Senior Director, Lead Discovery
Anvia Therapeutics Email Formats
Anvia Therapeutics uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@anviatx.com), used 77.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@anviatx.com | 77.8% |
{first initial}{last name} | jdoe@anviatx.com | 11.1% |
{last name}{last name} | doedoe@anviatx.com | 11.1% |
About Anvia Therapeutics
Anvia Therapeutics is developing small molecule inhibitors against clinically validated targets to expand treatment options for patients suffering from inflammatory and autoimmune diseases.
Anvia Therapeutics revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Anvia Therapeutics has 4 employees across 4 departments.
Departments
Number of employees
Funding Data
Anvia Therapeutics has never raised funding before.
Australia
Cyprus
Saudi Arabia
Frequently asked questions
4.8
40,000 users
